加载中
NASDAQHealthcareMedical - Devices
最新数据
US$58.45
−US$3.18 · -5.16%
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
收盘时
US$58.45
−US$3.18 · -5.16%
盘后
US$58.45
US$0.00 · 0.00%
10月13日 16:15 ET
盘中时间采用ET。市场数据可能有所延迟。
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
日内区间
当前US$58.45
52周区间
当前US$58.45
盘中时间采用ET。市场数据可能有所延迟。
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
日内区间
当前US$58.45
52周区间
当前US$58.45
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 2.11亿 USD | 1.66亿 USD | 1.65亿 USD | 1.62亿 USD | 1.27亿 USD |
| 销货成本 | 6476.8万 USD | 5650万 USD | 5817.4万 USD | 5510.5万 USD | 4127.8万 USD |
| 毛利 | 1.46亿 USD | 1.1亿 USD | 1.07亿 USD | 1.07亿 USD | 8540.4万 USD |
| 研究与开发 | 2024.7万 USD | 1970.6万 USD | 2642.8万 USD | 2026.9万 USD | 1831.5万 USD |
| 销售、一般及管理费用 | 1.65亿 USD | 1.4亿 USD | 1.46亿 USD | 1.26亿 USD | 9222.9万 USD |
| 营业费用 | 1.85亿 USD | 1.6亿 USD | 1.72亿 USD | 1.46亿 USD | 1.11亿 USD |
| 利息收入 | 42.3万 USD | 147.7万 USD | 102万 USD | 8.7万 USD | 2.3万 USD |
| 利息支出 | 2525.6万 USD | 2082.9万 USD | 1539.3万 USD | 1176万 USD | 906.2万 USD |
| 折旧和摊销 | 1047.4万 USD | 757.7万 USD | 488.3万 USD | 433.9万 USD | 412.4万 USD |
| 营业利润 | −3900.8万 USD | −4998.7万 USD | −6502.6万 USD | −3965.8万 USD | −2514万 USD |
| 净利润 | −5106.4万 USD | −8459.6万 USD | −7850.2万 USD | −7520.9万 USD | −4113.9万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
iShares Russell 2000 ETFIWM4280.16万0.06%787.4亿 USD0.19%US$276.7-0.43%
iShares Russell 2000 Growth ETFIWO1540.45万0.11%139.17亿 USD0.24%US$351.1-0.74%
Vanguard Russell 2000 ETFVTWO1080.03万0.06%180亿 USD0.06%US$111.77-0.45%
T. Rowe Price Small-Mid Cap ETFTMSL548.66万0.18%30.73亿 USD0.55%US$40.990.00%
Vanguard Health Care ETFVHT391.67万0.02%220亿 USD0.09%US$316.37-1.34%
Simplify Health Care ETFPINK340.96万1.07%3.18亿 USD0.51%US$37.79-1.79%
First Trust Small Cap Growth AlphaDEX FundFYC332.79万0.24%13.49亿 USD0.70%US$114.19-0.57%
Vanguard Russell 2000 Growth ETFVTWG205.06万0.12%17亿 USD0.06%US$256.21-0.80%iShares Russell 2000 ETFIWMiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOT. Rowe Price Small-Mid Cap ETFTMSLVanguard Health Care ETFVHTSimplify Health Care ETFPINKFirst Trust Small Cap Growth AlphaDEX FundFYCVanguard Russell 2000 Growth ETFVTWGAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
